• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Surg Oncol . A review of nasopharyngeal swab and saliva tests for SARS-CoV-2 infection: Disease timelines, relative sensitivities, and test optimi

tetano

Editor, Senior Moderator
J Surg Oncol


. 2021 Jun 6.
doi: 10.1002/jso.26561. Online ahead of print.
A review of nasopharyngeal swab and saliva tests for SARS-CoV-2 infection: Disease timelines, relative sensitivities, and test optimization


Marylin Roque[SUP] 1 [/SUP], Kevin Proudfoot[SUP] 1 [/SUP], Vadim Mathys[SUP] 1 [/SUP], Sophie Yu[SUP] 1 [/SUP], Natalie Krieger[SUP] 1 [/SUP], Thomas Gernon[SUP] 2 [/SUP], Kash Gokli[SUP] 1 [/SUP], Stanley Hamilton[SUP] 3 [/SUP], Colin Cook[SUP] 2 [/SUP], Yuman Fong[SUP] 2 [/SUP]



Affiliations

Abstract

Testing is an essential part of containment of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. This review summarizes studies for SARS-CoV-2 infection and testing. Nasopharyngeal samples are best at sensitivity detection, especially in early stages of disease and in asymptomatic individuals. Current swab processing involves a 100- to 1000-fold dilution of the patient sample. Future optimization of testing should focus on using smaller volumes of viral transport media and swab designs to increase comfort and increased viral adhesion.

Keywords: COVID-19; bronchitis; pharyngitis; pneumonia; respiratory infection.
 
Back
Top Bottom